1.
High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial
by Martineau, Adrian R, Dr
The Lancet (British edition), 2011, Vol.377 (9761), p.242-250
2.
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
by Munoz-Price, L Silvia, Dr
The Lancet infectious diseases, 2013, Vol.13 (9), p.785-796
3.
Epidemiology and clinical management of Legionnaires' disease
by Phin, Nick, Prof
The Lancet infectious diseases, 2014, Vol.14 (10), p.1011-1021
4.
Non-typeable Haemophilus influenzae , an under-recognised pathogen
by Van Eldere, Johan, Prof
The Lancet infectious diseases, 2014, Vol.14 (12), p.1281-1292
5.
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
by Pitout, Johann DD, Dr
The Lancet infectious diseases, 2008, Vol.8 (3), p.159-166
6.
Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial
by Christ-Crain, Mirjam
The Lancet (British edition), 2004-02-21, Vol.363 (9409), p.600-607
7.
Stenotrophomonas maltophilia : an emerging opportunist human pathogen
by Looney, W John, CSci FIBMS
The Lancet infectious diseases, 2009, Vol.9 (5), p.312-323
8.
Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study
by Nicol, Mark P, Prof
The Lancet infectious diseases, 2011, Vol.11 (11), p.819-824
9.
Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study
by Lawn, Stephen D, Dr
The Lancet infectious diseases, 2012, Vol.12 (3), p.201-209
10.
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections
by Karageorgopoulos, Drosos E, MD
The Lancet infectious diseases, 2008, Vol.8 (12), p.751-762
11.
Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study
by Lim, W S
Thorax, 2003-05, Vol.58 (5), p.377-382
12.
13.
Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analy...
by Morrison, Janina, MD
The Lancet infectious diseases, 2008, Vol.8 (6), p.359-368
14.
Rhodococcus equi infection
by Yamshchikov, Alexandra V, Dr
The Lancet infectious diseases, 2010, Vol.10 (5), p.350-359
15.
Diagnostic accuracy of same-day microscopy versus standard microscopy for pulmonary tuberculosis: a systematic review and meta-analysis
by Davis, J Lucian, Dr
The Lancet infectious diseases, 2013, Vol.13 (2), p.147-154
16.
A simple, valid, numerical score for grading chest x-ray severity in adult smear-positive pulmonary tuberculosis
by Ralph, Anna P
Thorax, 2010-10, Vol.65 (10), p.863-869
17.
Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes
by Getahun, Haileyesus, Dr
The Lancet (British edition), 2007, Vol.369 (9578), p.2042-2049
18.
Community-acquired pneumonia
by File, Thomas M
The Lancet (British edition), 2003-12-13, Vol.362 (9400), p.1991-2001
19.
Dual detection of Legionella pneumophila and Legionella species by real-time PCR targeting the 23S-5S rRNA gene spacer region
by Yang, G
Clinical microbiology and infection, 2010-03, Vol.16 (3), p.255-261
20.
Linezolid vs vancomycin: Analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia
by WUNDERINK, Richard G
Chest, 2003, Vol.124 (5), p.1789-1797
